Quercetin–Diazepam Mouse Study Combined Behavioral Tests With Receptor Modeling

The paper supports a preclinical interaction hypothesis rather than a demonstrated human supplement interaction.

What the publication shows

Mice received acute quercetin, with diazepam and flumazenil comparison conditions. Several exploratory behavior tests showed anxiolytic-like patterns, and the combination enhanced diazepam-associated effects. Flumazenil pretreatment altered those responses. Computational docking and simulation were used to explore possible GABA-related interactions.

Limits of the evidence

Injected experimental doses are not dietary exposure. Docking estimates do not establish receptor occupancy in people, and movement changes can complicate behavioral interpretation. The study did not measure clinical anxiety treatment or human respiratory safety.

Application to expert review

In an interaction opinion, distinguish an observed animal behavior from a proposed binding mechanism. Establish the actual supplement preparation, exposure and clinical findings before assigning any causal role to quercetin in a benzodiazepine case.

Source and related reading

Source: Publication PMC9656213. The case-review applications above are interpretive analysis.